pharma · Type 2 Diabetes Mellitus · Irritable Bowel Syndrome · LXRX
LEXICON PHARMACEUTICALS
LEXICON PHARMACEUTICALS, INC.
LEXICON PHARMACEUTICALS patent portfolio — 102 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- 8800 Technology Forest, The Woodlands, TX 77381, US
- Founded
- 1995
- Employees
- 282
- Programs
- 51
- Drugs
- 27
- Patents
- 102
LEXICON PHARMACEUTICALS patents
102 pharmaceutical patents indexed for LEXICON PHARMACEUTICALS. 4 expire within 24 months.
LEXICON PHARMACEUTICALS has 102 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 4 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12344596
Solid forms of (S)-1-((2′,6-bis(difluoromethyl)-[2,4′-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine and salts thereof
granted -
US 11730723
Compounds and methods for treating viral infections
granted -
US 11666575
Pyrazolo[1,5]pyrimidine-based compounds and methods of their use to treat viral infections
granted -
US 11059907
Antibodies that bind Notum Pectinacetylesterase
granted -
US 10106569
Inhibitors of sodium glucose transporter 1 for constipation
granted -
US 9862724
Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use
granted -
US 9688710
Inhibitors of sodium glucose cotransporter 1
granted -
US 9682982
Inhibitors of adapter associated kinase 1, compositions comprising them, and methods of their use
granted -
US 9624238
4H-thieno[3,2-C]chromene-based inhibitors of Notum Pectinacetylesterase and methods of their use
granted -
US 9403832
Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use
granted -
US 9365602
Sodium glucose co-transporter inhibitors and methods of their use
granted -
US 9200025
Inhibitors of sodium glucose cotransporter 1
granted -
US 9067962
Methods of treating diabetes
granted -
US 8969565
Imidazo[1,2-b]pyridazine-based compounds, compositions comprising them, and methods of their use
granted -
US 8946415
Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use
granted -
US 8772482
4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
granted -
US 8772483
Solid forms of (S)-2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoic acid
granted -
US 8772291
Multicyclic compounds and methods of their use
granted -
US 8742075
Monoclonal antibodies against ANGPTL3
granted -
US 8735408
Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate
granted -
US 8658682
(E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone dihydrate and methods of its use
granted -
US 8653094
Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)-pyrimidin-4-yl)phenyl)propanoate and methods of their use
granted -
US 8629156
Tryptophan hydroxylase inhibitors
granted -
US 8591891
Monoclonal antibodies against ANGPTL4
granted -
US 8507672
Substituted pyrrolo[2,3-d]pyrimidines as LIM kinase 2 inhibitors
granted -
US 8497271
Modulators of G protein-coupled receptor 88
granted -
US 8476413
Sulfanyl-tetrahydropyran-based compounds and methods of their use
granted -
US 8450332
LIMK2 inhibitors, compositions comprising them, and methods of their use
granted -
US 8450532
Compounds useful in the preparation of tryptophan hydroxylase inhibitors
granted -
US 8440652
MST1 kinase inhibitors and methods of their use
granted -
US 8426414
Modulators of G protein-coupled receptor 88
granted -
US 8410121
Methods of treating pulmonary hypertension
granted -
US 8404732
Methods of treating ulcerative colitis
granted -
US 8304577
Modulators of G protein-coupled receptor 88
granted -
US 8293878
Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors
granted -
US 8227661
Methods of identifying agents that ameliorate or modulate effects of PRO1328 gene disruptions
granted -
US 8217156
Solid forms of (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol and methods of their use
granted -
US 8193202
LIMK2 inhibitors, compositions comprising them, and methods of their use
granted -
US 8193204
Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1- (4-chloro-2-(3-methyl-1H-pyrazol-1-YL)phenyl)2,2,2-trifluoroethoxy)-pyrimidin-4-YL)phenyl)propanoate and methods of their use
granted -
US 8153804
Aryl pyridines and methods of their use
granted -
US 8093245
4-amino-1H-pyrimidin-2-one based compounds, compositions comprising them and methods of their use
granted -
US 8093246
O-linked pyrimidin-4-amine-based compounds, compositions comprising them, and methods of their use to treat cancer
granted -
US 8093267
Methods of treating rheumatoid arthritis
granted -
US 8093280
Methods of preparing imidazole-based compounds
granted -
US 8092796
Monoclonal antibodies against ANGPTL4
granted -
US 8093291
Methods of using and compositions comprising tryptophan hydroxylase inhibitors
granted -
US 8063057
Multicyclic amino acid derivatives and methods of their use
granted -
US 8026347
Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors
granted
Frequently asked questions
How many patents does LEXICON PHARMACEUTICALS have?
102 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do LEXICON PHARMACEUTICALS patents expire?
4 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.